AMS Centennial Fellowships for 2013-2014 Invitation for Applications

 

NEXT DEADLINE: DECEMBER 1, 2012

 

The AMS Centennial Research Fellowship Program makes awards annually to outstanding mathematicians to help further their careers in research. From 1997-2001, the fellowship program was aimed at recent PhDs. Recently, the AMS Council approved changes in the rules for the fellowships. The eligibility rules are as follows. The primary selection criterion for the Centennial Fellowship is the excellence of the candidate's research.

• Preference will be given to candidates who have not had extensive fellowship support in the past.
• Recipients may not hold the Centennial Fellowship concurrently with another research fellowship such as a Sloan or NSF Postdoctoral fellowship.
• Under normal circumstances, the fellowship cannot be deferred.
• A recipient of the fellowship shall have held his or her doctoral degree for at least three years and not more than twelve years at the inception of the award (that is, received between September 1, 2001 and September 1, 2010).
• Applications will be accepted from those currently holding a tenured, tenure track, post-doctoral, or comparable (at the discretion of the selection committee) position at an institution in North America.

The stipend for fellowships awarded for 2013-2014 was US$82,000, with an additional expense allowance of about US$8200. Acceptance of the fellowship cannot be postponed.
The number of fellowships to be awarded is small and depends on the amount of money contributed to the program. The Society supplements contributions as needed. One fellowship will be awarded for the 2013-2014 academic year. 

More information

US AID Development Innovation Ventures

Testing Promising Solutions, Scaling Proven Successes

Let's start with the problem: America is facing a time of fiscal austerity. Meanwhile, around the globe, development challenges of devastating scale continue to drive a strong moral and strategic imperative for the United States to stay a leader in international development.  Given budget constraints, we need to work harder than ever to find solutions that get the biggest bang for our development bucks. 

In October 2010, USAID launched Development Innovation Ventures.  Through DIV, USAID awards grants to compelling new development solutions, rigorously tests them, and helps scale those that are proven successful to become development grand slams.

How it works

First, we run a competition for ideas.  We recognize that development breakthroughs can come from anywhere—a lab in a university, a local person who has deep contextual knowledge, or a passionate entrepreneur. Perhaps it will come from you.

We seek solutions that are several times more cost effective than current practice. These ideas do not have to be technological solutions, but also new business models, new processes, or even novel combinations of tried and true techniques. We look for the solutions potential to scale big, to tens of millions of beneficiaries within ten years. 

Next, we test if the idea delivers the targeted development outcomes, and at a dramatically lower cost than current best practice. We use rigorous and cutting-edge methods for evaluating project impact. Many of our current grants include randomized trials of development interventions, comparing treatment groups to control groups to analyze development impact. As part of our model, we give out our awards incrementally—if your idea works, and only if it works, you can compete for additional stages of funding.

We fund ideas that are in different phases of rollout, and depending on their current phase applicants can propose a project in any of the three stages below.  To move from one stage from the next, applicants must re-compete.

STAGE ONE is for projects in the proof of concept phase: DIV will grant these projects up to $100,000 dollars over one year so that grantees can refine prototypes and gather the evidence they need to pull in more investment and grow. 

STAGE TWO is for larger projects, typically to expand across a country. DIV will grant Stage Two projects up to $1 million.  In exchange, Stage Two projects will build in rigorous testing to prove if the project is viable at its larger size.

STAGE THREE is for much larger projects.  For grants of up to $15 million over several years, solutions that have already proven to work at a large scale will be expanded much further, and often into multiple countries.

More information.

US Japan Society December 15 Deadline

US-Japan Policy

Throughout our 20-year history, the Foundation has supported a variety of policy-related studies, initiatives and exchanges in pursuit of our mission: to promote stronger ties between the United States and Japan through greater mutual knowledge and understanding, to increase broad awareness of important policy issues, and to address common concerns in the Asia-Pacific region through the US-Japan perspective.

The Foundations Policy Program is one category of our grant-making activity. The other two categories are: 1) pre-college education; and 2)communication / public opinion. 

Link here for more information.

Application Deadlines

The Foundation welcomes Letters of Inquiry anytime during the year, but not later than December 15 for the Spring Grant Cycle and July 15 for the Fall Grant Cycle. The Foundation cannot gurantee that Letters of Inquiry received after these dates will be considered for the current grant cycle. Letters of Inquiry will be reviewed and decisions to invite a Full Proposal will be sent as soon as possible .

Full Proposals must be received by January 31 for the Spring Cycle and August 31 for the Fall Cycle. The USJF Board meets in April and October when funding decisions are made. Funding decisions are announced shortly after these meetings.

April Funding Cycle
By December 15	Suggested submission date for Letters of Inquiry. Please note that in spite of this deadline, applicants are encouraged to submit a Letter of Inquiry as early as practicably possible for review. We are unable to guarantee that those submitted close to the deadline will be reviewed and they may have to wait for the next cycle.
December 15-Janaury 15	Letters of Inquiry will be reviewed and responses sent as soon as possible.
January 31	Deadline for receipt of Full Proposal (only invited Full Proposals will be considered)
February/March	Internal / External review of Full Proposals
April	USJF Board of Trustees meet to review Full Proposals, make funding decisions
May	Funding decisions announced

Gerber Foundation Research Grants

RESEARCH INTERESTS                                                    

The Gerber Foundation’s mission focuses on the nutrition, care and development of infants and young children. Therefore, grant-making interests are focused on health and/or nutrition-related research having a significant impact on issues facing infants and young children from the first year before birth to age 3.

The Foundation is particularly interested in fresh approaches to solving newborn or pediatric problems or emerging issues with a predictable time frame to clinical application. Projects should be focused on issues faced by care providers that, when implemented, will improve the health, nutrition and/or developmental outcomes for infants and young children. Projects may include:

• Etiologic mechanisms of disease
• New, improved or less invasive diagnostic procedures
• Reduction or elimination of side effects
• Alleviation of symptoms
• New, improved or less invasive therapies, care, or treatments
• Dosage or dosing requirements or mechanisms for drugs, nutrient supplementation or other therapeutic measures (under or overdosing)
• Preventative measures

Competitive requests will be focused in a way to achieve measurable outcomes that could result in systemic practice changes within a reasonable period of time.

The Foundation gives priority to projects of national or regional impact. Foundation support is not typically ongoing. Project outcomes should be of sufficient impact, if successful, to generate long-term support from other sources.

What We Do Not Fund

While we endeavor to maintain a high degree of flexibility in our programming, we do observe several practical limitations. We do not make grants or loans:

• To individuals
• For operating support
• For endowment support
• For national child welfare programs
• For international based programs
• For product testing related to commercialization purposes
• For exclusive food or baby products giveaway programs
• Capital campaign support outside of the West Michigan giving area

More information

Pulmonary Fibrosis Foundation

Letters of Intent for 2013 Grant Cycle
Now Being Accepted

I.M. Rosenzweig Young Investigator Awards

Albert Rose Established Investigator Awards

The Pulmonary Fibrosis Foundation is accepting Letters of Intent for its 2013 PFF Research Fund grants.

One of the primary goals of the PFF Research Fund is to support research that will ultimately lead to successful therapies for idiopathic pulmonary fibrosis. In pursuit of this goal, the foundation has funded over $3 million in basic and clinical research. The fund supports investigations that offer a high likelihood of improving the understanding of pulmonary fibrosis in basic science, translational research, clinical research, and social science/quality of life.

In 2012, the foundation established two new awards named after its co-founders — the I.M. Rosenzweig Young Investigator Awards and the Albert Rose Established Investigator Awards.

The Young Investigator Awards are designed to encourage young investigators (individuals within five years of completion of their formal training) to maintain and enhance their interest in PF research during the early stages of their academic career.

The Established Investigator Awards are designed for individuals planning to explore innovative areas of research that may not yet be eligible for aNational Institutes of Health (or similar) grant.

Each of the programs will present two awards, with each recipient receiving up to $50,000 over a two-year period.

For further information and access to proposal guidelines and application instructions, visit the Pulmonary Fibrosis Foundation Web site.

Contact:
Link to Complete RFP

EPILEPSY THERAPY PROJECT ANNOUNCES SECOND ANNUAL “SHARK TANK” COMPETITION

Washington, D.C., OCTOBER 25, 2012 -- The Epilepsy Therapy Project (ETP), a non-profit organization whose mission is to accelerate new therapies for people living with epilepsy and seizures, and the parent organization of epilepsy.com, today announced its second annual “Shark Tank” Competition. ETP is inviting entries that represent the most innovative new ideas in epilepsy treatment and care. The deadline for submission is January 15, 2013 at 6 p.m. Eastern. The winner of the 2013 Shark Tank Competition will receive national recognition and a $100,000 cash award to support the development and commercialization of an important new product, technology or therapeutic concept.

The top finalists will present their product concepts or therapeutic candidates at the Antiepileptic Drug and Device Trials (AEDD) XII Conference in Miami being held on May 15-17, 2013. The winning entry will be selected by live voting at the conference by an expert panel of judges and audience members representing industry, patient advocacy, investment, research and medical communities. The project deemed most innovative will be announced at the conclusion of the conference, and the winner will receive a $100,000 grant to help accelerate the idea from concept to people with epilepsy. Contest finalists will also benefit from exposure to industry executives and investors. Shark Tank finalists will be notified by February 15, 2013 and are eligible for a travel stipend to attend the AEDD conference.

More

DOE Early Career Program

The Office of Science of the Department of Energy announces the fiscal year 2013 Early Career Research Program. The funding opportunity for researchers in universities and DOE national laboratories was announced July 20, 2012. The Early Career Research Program, now in its fourth year, supports the development of individual research programs of outstanding scientists early in their careers and stimulates research careers in the disciplines supported by the DOE Office of Science. Opportunities exist in the following program areas: Advanced Scientific Computing Research (ASCR); Biological and Environmental Research (BER); Basic Energy Sciences (BES), Fusion Energy Sciences (FES); High Energy Physics (HEP), and Nuclear Physics (NP). Mandatory pre-applications are due at 5 pm eastern time on September 6, 2012. Only those applicants that receive notification from DOE encouraging a formal application may submit full applications. Full applications from those encouraged to submit them are due by 5 pm eastern time November 26, 2012.

Link to announcement

CareFusion Foundation Announces Grant Program to Support Infection Prevention at Healthcare Organizations

The CareFusion Foundation has announced the launch of the Clinical Excellence Grant program, a new funding initiative designed to help identify and share infection prevention best practices across hospitals and healthcare facilities in the United States.

The foundation is inviting grant proposals aimed at improving infection prevention. The foundation will award a total of $500,000 in one-time grants of up to $50,000 to eligible nonprofit healthcare institutions to help fund clinical programs that improve infection prevention practices or outcomes.

Grants will be awarded to programs that either 1) Help implement measurable clinical initiatives to improve infection prevention practices, protocols, or outcomes within a healthcare setting; or 2) Support hospital-led patient education or outreach related to infection prevention within the hospital's local community. Preference will be given to programs that can be measured for impact and that demonstrate scalability and potential to be shared as a best practice.

The grant program is open to all U.S.-based nonprofit healthcare institutions.

The foundation will not support requests for any capital/building expenses, fundraisers, general operations, continuing education, scholarships, or entertainment functions.

Complete program guidelines, eligibility requirements, and application instructions are available at the CareFusion Web site.

Contact:
Link to Complete RFP

Uniting Against Lung Cancer and the National Lung Cancer Partnership Announce Impact Award

Uniting Against Lung Cancer and the National Lung Cancer Partnership Announce Impact Award

Uniting Against Lung Cancer and the National Lung Cancer Partnership have announced that they will be jointly sponsoring the Impact Award, a new $200,000 research grant designed to accelerate the movement of promising ideas in lung cancer research into clinical application. The award is intended to rapidly bring new advances to the clinic and positively impact patient care.

The award is intended to support clinical translational research that will promote significant improvements over current approaches in lung cancer prevention, detection, or therapy. Applicants are expected to demonstrate an ability to produce significant progress for lung cancer patients in the near term. Applicants must present a strategic plan and timeline for clinical implementation within five years of the start of the two-year award period.

At the time of application, the principal investigator must hold a position at or above the level of assistant professor at a not-for-profit sponsoring institutions in the United States. Collaborations with industry partners are encouraged; however, the PI must be an academic researcher.

The award provides funding of $200,000, including a maximum of $18,000 in indirect costs. Grants will be paid over two years at $100,000per year. Grant funds may not be used for tuition, travel, or permanent equipment costs.

Complete program information and application instructions are available at the Uniting Against Lung Cancer Web site.

Contact:
Link to Complete RFP

Primary Subject: Medical Research
Geographic Funding Area: National

Junior Researchers in United States and Israel Invited to Apply for New Investigator Awards in Alzheimer's Disease

Funded by the Rosalinde and Arthur Gilbert Foundation and the Diane and Guilford Glazer Foundation and administered by the American Federation for Aging Research, the New Investigator Awards in Alzheimer's Disease program is designed to support research in areas in which more scientific investigation is needed to improve the prevention, diagnosis, and treatment of Alzheimer's disease. The program also serves to encourage junior investigators in the United States and Israel to pursue research and academic careers in the neurosciences, and Alzheimer's disease in particular.

Projects in basic and translational research related to Alzheimer's disease that are clinically relevant will be considered. Projects that focus on healthy brain aging also will be considered. Areas of research could, for example, include learning and memory, nutrition, exercise, and cardiovascular risk factors as they relate to the brain and the aging process.

Applicants must be independent investigators with independent research space, and must be no more than ten years beyond the start of their postdoctoral research training as of July 1, 2013. (Exceptions to the ten-year rule may be requested for unusual circumstances.) The proposed research must be conducted at any type of not-for-profit setting in the United States or Israel.

It is anticipated that up to four grants of $100,000 will be awarded in 2013. Applicants may propose to use the award over the course of one or two years as justified by the proposed research. Up to 8 percent of funds may be budgeted for overhead or indirect costs (not to exceed $7,407).

Complete program guidelines and application instructions are available at the AFAR Web site.

Contact:
Link to Complete RFhttp://www.afar.org/research/funding/new-investigator-awards/

NIH will Transition to Research Performance Progress Report (RPPR)

Progress reports are required annually to document grantee accomplishments and compliance with terms of award. They describe scientific progress, identify significant changes, report on personnel, and describe plans for the subsequent budget period or year.

The Office of Management and Budget (OMB) has mandated that federal agencies implement a federal-wide research performance progress report (RPPR) for submission of required annual or other interim performance reporting on research grant and cooperative agreement awards to standardize recipient reporting on federally-funded research projects.

Implementation of the RPPR

All NIH grantees will have the option to use the RPPR for Streamlined Non-competing Award Process (SNAP) and Fellowship progress reports beginning 10/19/2012. The use of the RPPR will not be required at this time and grantees may continue to use eSNAP or paper submissions as appropriate. A full list of activity codes for which grantees will be able to submit RPPRs as of 10/19/2012 appears below:

	Activity Codes
R01-like SNAPs	D71, DP1, DP5, G08, G11, G13, P40, R00, R01, R03, R18, R21, R33, R34, R36, R37, R56, RC1, RC2, RL1, S10, S21, S22, SC1, SC2, SC3, UB1, UC2, UH1, UH2, UH3, UP5, P01, P20, P30, P40, P41, P50, PL1, R24, S11, U01, U10, U19, U24, U34, U54
Individual K SNAPs	K01, K02, K05, K06, K07, K08, K18, K22, K23, K24, K25, K26, K99, KL1
Education SNAPs	D43, K30, R13, R25, RL5, T14, T36, U13, U2R
Fellowships	F05, F30, F31, F32, F33, F34, F37
SBIR/STTR SNAPs	R41, R42, R43, R44, U43, U44

For additional information and to watch a webinar, please go to NIH website.

PCAST Releases Report on Drug Development

PCAST Releases Report on Drug Development. The President's Council of Advisors on Science and Technology (PCAST) has released a new report (PDF) on innovation in drug discovery and development, noting the challenges present in translating basic research discoveries into clinical applications. The report's recommendations include (a) the formation of a public-private partnership with the aim of accelerating drug development, and (b) the commissioning of a study to assess ways to encourage drug companies to invest in critical -- but not necessarily financially attractive -- products to enhance public health.

OMB Releases Budget Guidelines, Restricts Federal Travel Expenditures

This May, the White House Office of Management and Budget (OMB) issued a memo of guidelines to executive departments and agencies focused on reducing agency budgets for travel, conferences, real estate, and vehicle fleet management. The guidelines, as well as the related OMB blog post, pointed to these measures as increasing government stewardship of taxpayer money, enhancing efficiency in government spending, and strengthening accountability in budget expenditures. Many scientific societies are monitoring the impacts of the guidelines on scientific conferences.

N.H. Inspires Innovation Program Hosts Webinar, Workshop for Tech Companies to Learn About Federal Funding

DURHAM, N.H. – N.H. Inspires Innovation will host two events for early-stage technology companies that want more information about the federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.


N.H. Inspires Innovation, designed to bring SBIR grant information and advice to New Hampshire companies and increase opportunities for growth of federal- and state-funded research partnerships, will offer a one-hour webinar covering the basics of SBIR/STTR intended to help technology entrepreneurs decide if they want to attend, and a 1.5-day SBIR/STTR National Institutes of Health Proposal Workshop.

The webinar will be held from 11:30 to 12:30 p.m., Tuesday, Oct. 9, 2012. Register online at www3.gotomeeting.com/register/846933950.

The workshop will be held Tuesday, Oct. 16, and Wednesday, Oct. 17, 2012, in Hanover. Details and registration are online at www.nhsbdc.org/nh-inspires-innovation.

Through the SBIR/STTR programs, 11 federal agencies make more than $2 billion in high-risk, nondilutive capital available to fund research and development at innovative, small companies annually.

“Submitting an SBIR or STTR proposal is a rigorous process, so before companies jump into the more intensive training it takes to be competitive, we offer this webinar to provide at-a-glance information about the programs, what it takes to qualify and what you’ll need if you move forward,” said Mary Collins, state director of the New Hamshire Small Business Development Center (NH SBDC). “For those who decide to move forward with proposals for the National Institutes of Health, the Oct. 16 and 17 workshop will do a deep dive into actual proposal preparation.”

Lisa Kurek, managing partner, BBC Entrepreneurial Training & Consulting, will conduct both the webinar and the workshop. Kurek has extensive experience not only in the SBIR/STTR programs, but in product and business development, and sales and product management with large, publicly-held corporations as well as small start-ups.

N.H. Inspires Innovation is a collaboration of New Hampshire Innovation Research Center (NHIRC), New Hampshire Small Business Development Center and the University of New Hampshire, designed to bring SBIR grant information and advice to New Hampshire companies, thereby increasing opportunities for growth of federal- and state-funded research partnerships.

NH SBDC is an outreach program of the UNH Whittemore School of Business and Economics, and a cooperative venture of the U.S. Small Business Administration, State of New Hampshire (DRED), University System of New Hampshire, and the private sector. A part of 64 SBDC programs nationwide, the NH SBDC was fully accredited in 2010 by the Association of Small Business Development Centers. The NH SBDC has advised businesses for 26 years, helping 8,000 businesses create and retain more than 4,500 jobs over the last decade.
The NHIRC was created in 1991 by the New Hampshire Legislature to increase collaboration, technology development, and innovation between New Hampshire businesses and universities. Businesses propose projects in collaboration with researchers, typically at Dartmouth or UNH. Companies then match their project awards to fund the research which often leads to new production methods, products, companies, and jobs. Since its inception, the NHIRC has helped create more than 650 jobs throughout the state and its awardees have received more than $900 million in follow-on capital.

Defense Health Program Breast Cancer

Defense Health Program  Department of Defense Breast Cancer Research Program Funding Opportunities for Fiscal Year 2013
The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $120 million (M) to the Department of Defense Breast Cancer Research Program (BCRP) to support innovative, high-impact breast cancer research. The BCRP is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).


Please inform researchers interested in breast cancer funding opportunities that the Congressionally Directed Medical Research Programs (CDMRP) has released the following Breast Cancer Research Program (BCRP) funding mechanism for Fiscal Year 2012. Please consider sending this News Release on to your bio-medical, life science investigators focused on breast cancer research

http://cdmrp.army.mil/funding/pa/12bcrppostdoc2_pa.pdf

Postdoctoral Fellowship Award – Pre-application deadline is December 4, 2012

Eligibility - Principal Investigator: Doctoral graduates (Ph.D. or M.D.).

Clinical investigators are eligible to apply. Must have no more than 2 years experience in the proposed research setting and no more than 4 years of postdoctoral research experience as of the application deadline

Mentor or formal co-mentor must have breast cancer research experience, including current funding and publications.

Key Mechanism Elements:

• Supports the training of exceptionally talented recent doctoral or medical graduates who have demonstrated that they are the “best and brightest” of their peers.

• Individualized training program and mentorship should prepare the PI for an independent career at the forefront of breast cancer research.

• Proposed research should address a critical problem in breast cancer



Maximum funding of $300,000 for direct costs ($100,000 per year, plus indirect costs).

Period of performance not to exceed 3 years.

All applications must conform to the final program announcement and application instructions that are available for electronic downloading from the Grants.gov website. The application package containing the required forms will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline of December 4, 2012. Applications must be submitted through the federal government’s single-entry portal, Grants.gov. Requests for email notification of the program announcement release may be sent to help@cdmrp.org. For more information about the BCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).



Point of Contact:

CDMRP Helpdesk

301-682-5507

help@cdmrp.org

NSF Issues PAPPG Effective January 2013

A new version of the NSF Proposal & Award Policies & Procedures Guide (PAPPG), (NSF 13-1) has been issued. The PAPPG is comprised of documents relating to the Foundation's proposal and award process and consists of the:


(a) Grant Proposal Guide (GPG) for guidance on the preparation and submission of proposals to NSF; and

(b) Award & Administration Guide (AAG) to guide, manage, and monitor the award and administration of grants and cooperative agreements made by the Foundation. This new version of the PAPPG will be effective for proposals submitted, or due, on or after January 14, 2013. Significant changes include:
• Revisions to the NSF Merit Review Criteria which implement the National Science Board’s (NSB) recommendations. Changes will affect the project summary and project description sections of proposals. Annual and final reports also will be affected;
• Revision of the Biographical Sketch(es) instructions to rename the “Publications” section to “Products” and amend terminology and instructions accordingly;


• Clarification on indirect costs specifying that, except as noted in the PAPPG or a program solicitation, organizations must use the applicable negotiated indirect cost rate;

• Modification of Facilities, Equipment and Other Resources section of proposals to assist proposers in complying with the NSF cost sharing policy;


• Additional proposal certifications must be submitted by the Authorized Organizational Representative (AOR) covering organizational support of the proposed research, tax obligations/liability and felony convictions; and



• Numerous other clarifications also have been made throughout the document.



A by-chapter summary of the changes is provided at the beginning of both the Grant Proposal Guide and the Award & Administration Guide to assist with identifying the changes.



Because the revisions to the merit review criteria will have broad repercussions for NSF staff, proposers and reviewers, the Foundation is conducting extensive outreach to the internal and external NSF communities. This purposeful communication is intended to ensure a broad understanding of the revisions to the merit review criteria and provide easy access to supporting materials including:

• A revised NSF Merit Review website with updated information about the revisions;

• A resource website for the proposer community containing presentations, fact sheets and other important links; and

• A webcast in November 2012 covering all of the PAPPG revisions (send an e-mail to policy@nsf.gov to be notified when this webcast is available).


While this version of the PAPPG becomes effective on January 14, 2013, in the interim, the guidelines contained in the current PAPPG (NSF 11-1) continue to apply. We will ensure that the current version of the PAPPG remains on the NSF website, with a notation to proposers that specifies when the new PAPPG (including a link to the new Guide) will become effective.
In addition, we plan to revise existing funding opportunities to alert proposers that significant changes have been made to NSF proposal preparation guidelines. Please direct any questions to the Policy Office in the Division of Institution & Award Support at policy@nsf.gov, or (703) 292-8243.

Doris Duke Charitable Foundation Announces International Clinical Research Fellowships for Medical Students

New York, N.Y., October 4, 2012 – The Doris Duke Charitable Foundation (DDCF) announced today that it will award $5.2 million in grants to six U.S.-based institutions to offer International Clinical Research Fellowships (ICRF) to medical students.


The goal of ICRF is to encourage medical students to pursue clinical research careers by exposing them to exciting research opportunities in developing countries. Each institution will offer three fellowships per year over four years beginning in the summer of 2013. Students participating in the ICRF program will take a year out from medical school to conduct clinical research abroad under the direction of a mentor working in global health, as well as complete related coursework.

The following institutions will offer Doris Duke International Clinical Research Fellowships:

Duke University School of Medicine and Duke Global Health Institute Harvard Medical School University of California, San Francisco, School of Medicine University of Minnesota School of Medicine University of North Carolina at Chapel Hill School of Medicine Yale University School of Medicine

The application process for the 2013-2014 fellowship year begins in November, and applications are due January 15, 2013. Students may be matriculated at any U.S.-based medical school to be eligible for the ICRF.

“We look forward to working with these institutions to give medical students the unique opportunity to participate in an outstanding clinical research project in a low or middle-income country. Our hope is that this experience will motivate students to become the next generation of doctors conducting research in global health,” said Betsy Myers, Program Director for Medical Research.

Page 2 of 2

About the Medical Research Program

Since 1998, the foundation’s Medical Research Program has committed approximately $259 million to strengthen and support clinical research that advances the translation of biomedical discoveries into new treatments, preventions and cures for human diseases. To learn more about the program or to sign up to receive competition announcements, visit www.ddcf.org.

About the Doris Duke Charitable Foundation

The mission of the Doris Duke Charitable Foundation is to improve the quality of people’s lives through grants supporting the performing arts, environmental conservation, medical research and the prevention of child abuse and neglect, and through preservation of the cultural and environmental legacy of Doris Duke’s properties.

About Doris Duke on the Centenary of Her Birth Born on November 22, 1912 in New York City, Doris Duke was the only child of John Buchanan (J.B.) Duke, a founder of the American Tobacco Company and Duke Energy Company. When J.B. Duke died in 1925, he divided his fortune between Doris, who was then only 12 years old, and the Duke Endowment. Intelligent, adventurous, and independent, Doris Duke used her wealth to pursue her many interests, which included the arts, historic preservation and environmental conservation, and to fund a variety of public causes, including medical research and child welfare. When she was just 21, she established a foundation called Independent Aid through which she gave away the equivalent of hundreds of millions in today’s dollars—often as anonymous contributions. As a lifelong philanthropist, she was a frequent supporter of hospitals and research centers as well as an early funder of AIDS research. At age 56, she also established the Newport Restoration Foundation (NRF) to save the rapidly disappearing 18th-century architecture in Newport, Rhode Island. Finally, through her will, she established her ongoing legacy by calling for the creation of the Doris Duke Charitable Foundation (DDCF), which has to date awarded more than $1 billion in grants. (www.ddcf.org)